Filing Flows › Niagen Bioscience (NAGE) › How it makes money
How Niagen Bioscience (NAGE) makes money
Niagen Bioscience (NAGE) made $27.1M of revenue in the third quarter 2026 (Q3 2026), -18% from a year earlier. Consumer Products segment brought in $23.3M (86%); Ingredients segment brought in $3.8M (14%).
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Consumer Products segment | $23.3M | 86.0% | -3% | -10% |
| Ingredients segment | $3.8M | 14.0% | -29% | -47% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $27.1M | 100.0% |
| Operating cash flow | $2.6M | 9.7% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $27.2M | -20% |
| Q2 2026 | $29.8M | -4% |
| Q1 2026 | $31.5M | +3% |
| Q4 2025 | $33.8M | +16% |
| Q3 2025 | $34.0M | +33% |
| Q2 2025 | $31.1M | +37% |
| Q1 2025 | $30.5M | +38% |
From Niagen Bioscience's 10-Q filed Nov 4, 2026 (on EDGAR).
Questions
How does Niagen Bioscience make money?
Niagen Bioscience (NAGE) made $27.1M of revenue in the third quarter 2026 (Q3 2026), -18% from a year earlier. Consumer Products segment brought in $23.3M (86%); Ingredients segment brought in $3.8M (14%).
What is Niagen Bioscience's biggest business?
Consumer Products segment: $23.3M in the third quarter 2026, 86% of revenue, -10% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.